Function | Term | Count | PValue | Genes |
---|---|---|---|---|
biological processes | GO:0007588 ~ excretion | 7 | 2.64E-07 | NPHS2, CLCNKB, UMOD, ATP6V1B1, ATP6V0A4, KCNJ1, AQP2 |
GO:0001666 ~ response to hypoxia | 11 | 5.42E-07 | CAV1, NOL3, CA9, PLOD2, CXCR4, EGLN3, TLR2, HSD11B2, ABAT, CASP1, ANGPTL4 | |
GO:0090383 ~ phagosome acidification | 4 | 9.87E-04 | ATP6V1G3, ATP6V1B1, ATP6V0A4, ATP6V0D2 | |
GO:0033572 ~ transferrin transport | 4 | 0.002115 | ATP6V1G3, ATP6V1B1, ATP6V0A4, ATP6V0D2 | |
GO:0008286 ~ insulin receptor signaling pathway | 5 | 0.002575 | CAV2, ATP6V1G3, ATP6V1B1, ATP6V0A4, ATP6V0D2 | |
GO:0032755 ~ positive regulation of interleukin-6 production | 4 | 0.004349 | P2RX7, TLR2, FCER1G, TLR3 | |
GO:0034220 ~ ion transmembrane transport | 7 | 0.004506 | FXYD4, CLCNKB, ATP6V1G3, ATP6V1B1, ATP6V0A4, ATP6V0D2, AQP2 | |
GO:0015695 ~ organic cation transport | 3 | 0.00525 | RHCG, SLC7A8, RHBG | |
GO:0006885 ~ regulation of pH | 3 | 0.005972 | RHCG, ATP6V1B1, ATP6V0A4 | |
GO:0090090 ~ negative regulation of canonical Wnt signaling pathway | 6 | 0.006989 | CTHRC1, CAV1, SOST, GPC3, SFRP1, PSMB9 | |
GO:0042493 ~ response to drug | 8 | 0.007086 | P2RX7, CA9, SFRP1, LGALS1, SLC34A1, HSD11B2, ABAT, NNMT | |
GO:0008152 ~ metabolic process | 6 | 0.007913 | ENPP6, LPCAT1, SUCLG1, MAN1C1, ACSF2, ACAA1 | |
GO:0032092 ~ positive regulation of protein binding | 4 | 0.010136 | CTHRC1, CAV1, PLK2, TRIB3 | |
GO:0055074 ~ calcium ion homeostasis | 3 | 0.011171 | CAV1, ATP6V1B1, CALB1 | |
GO:0006508 ~ proteolysis | 10 | 0.011293 | C1QA, C1QB, GGT6, SFRP1, C3, CTSS, CASP1, PLG, DPEP1, XPNPEP2 | |
GO:0055114 ~ oxidation-reduction process | 11 | 0.011711 | ALDH6A1, TYRP1, PLOD2, NDUFA4L2, RRM2, EGLN3, HSD11B2, ALDH4A1, DIO1, DCXR, HPD | |
GO:0010951 ~ negative regulation of endopeptidase activity | 5 | 0.012067 | KNG1, C3, SERPINA5, HRG, CSTA | |
GO:0050900 ~ leukocyte migration | 5 | 0.012407 | SLC16A3, CAV1, SLC7A8, FCER1G, ITGB2 | |
GO:0045880 ~ positive regulation of smoothened signaling pathway | 3 | 0.013221 | GPC3, SFRP1, FGF9 | |
GO:0001798 ~ positive regulation of type IIa hypersensitivity | 2 | 0.014597 | C3, FCER1G | |
GO:2000054 ~ negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification | 2 | 0.014597 | SOST, SFRP1 | |
GO:0061621 ~ canonical glycolysis | 3 | 0.01542 | ENO2, PFKP, HK2 | |
GO:0001503 ~ ossification | 4 | 0.020939 | SOST, SLC34A1, ATP6V1B1, ATP6V0A4 | |
GO:0006954 ~ inflammatory response | 8 | 0.021562 | KNG1, TNFAIP6, P2RX7, CXCR4, C3, TLR2, TLR3, ITGB2 | |
GO:0050717 ~ positive regulation of interleukin-1 alpha secretion | 2 | 0.021815 | P2RX7, CASP1 | |
GO:2000116 ~ regulation of cysteine-type endopeptidase activity | 2 | 0.021815 | BIRC3, PSMB9 | |
GO:0070634 ~ transepithelial ammonium transport | 2 | 0.021815 | RHCG, RHBG | |
GO:0019065 ~ receptor-mediated endocytosis of virus by host cell | 2 | 0.021815 | CAV2, CAV1 | |
GO:0015991 ~ ATP hydrolysis coupled proton transport | 3 | 0.022874 | ATP6V1B1, ATP6V0A4, ATP6V0D2 | |
GO:0051480 ~ regulation of cytosolic calcium ion concentration | 3 | 0.022874 | CAV1, PVALB, CALB1 | |
GO:0001525 ~ angiogenesis | 6 | 0.024169 | CAV1, FGF9, TGFBI, HRG, FGF1, ANGPTL4 | |
GO:0002931 ~ response to ischemia | 3 | 0.024234 | CAV1, NOL3, HK2 | |
GO:0072221 ~ metanephric distal convoluted tubule development | 2 | 0.028982 | UMOD, CALB1 | |
GO:0002283 ~ neutrophil activation involved in immune response | 2 | 0.028982 | FCER1G, TYROBP | |
GO:0007162 ~ negative regulation of cell adhesion | 3 | 0.029996 | KNG1, TGFBI, HRG | |
GO:0006955 ~ immune response | 8 | 0.03533 | RGS1, TNFSF13B, C3, ENPP3, TLR2, CTSS, FCGR3A, FCGR3B | |
GO:0070836 ~ caveola assembly | 2 | 0.036096 | CAV2, CAV1 | |
GO:0015696 ~ ammonium transport | 2 | 0.036096 | RHCG, RHBG | |
GO:0006873 ~ cellular ion homeostasis | 2 | 0.036096 | RHCG, SLC4A1 | |
GO:0019740 ~ nitrogen utilization | 2 | 0.036096 | RHCG, RHBG | |
GO:0010543 ~ regulation of platelet activation | 2 | 0.036096 | FCER1G, HRG | |
GO:0051005 ~ negative regulation of lipoprotein lipase activity | 2 | 0.036096 | APOC1, ANGPTL4 | |
GO:0034123 ~ positive regulation of toll-like receptor signaling pathway | 2 | 0.036096 | TLR2, TLR3 | |
GO:0031623 ~ receptor internalization | 3 | 0.039536 | CAV1, FCER1G, ITGB2 | |
GO:0006094 ~ gluconeogenesis | 3 | 0.041225 | ENO2, FBP1, PCK2 | |
GO:0050776 ~ regulation of immune response | 5 | 0.041952 | C3, ITGB2, FCGR3A, TREM2, TYROBP | |
GO:0030514 ~ negative regulation of BMP signaling pathway | 3 | 0.04294 | CAV1, SOST, SFRP1 | |
GO:0000187 ~ activation of MAPK activity | 4 | 0.043944 | P2RX7, CXCR4, FGF1, DUSP9 | |
GO:0007596 ~ blood coagulation | 5 | 0.046407 | P2RX7, SERPINA5, FCER1G, ENTPD1, PLG | |
GO:0032760 ~ positive regulation of tumor necrosis factor production | 3 | 0.046448 | TLR2, FCER1G, TLR3 | |
cell composition | GO:0070062 ~ extracellular exosome | 61 | 4.70E-17 | FGF9, SLC7A8, CALB1, AQP2, EFHD1, GPC3, PVALB, CXCR4, PLOD2, SERPINA5, TMEM52B, TGFBI, SLC4A1, FCGR3A, ATP6V0D2, FCGR3B, DPEP1, HPD, KNG1, ALDH6A1, CRYAA, SUCLG1, SLC22A8, PFKP, FBP1, C1QA, C1QB, RHCG, MNDA, ABAT, CSTA, CHL1, SH3GL2, ENPP6, C3, ENPP3, APOC1, ITGB2, UMOD, ATP6V1B1, ENO2, HS6ST2, HRG, SUCNR1, ENTPD1, SLC12A3, LGALS1, PCK2, MAN1C1, PLG, PSMB9, XPNPEP2, AFM, GGT6, SFRP1, NPHS2, SLC13A3, FABP1, ATP6V0A4, IGFBP3, DCXR |
GO:0016323 ~ basolateral plasma membrane | 12 | 6.23E-08 | CLDN8, CAV1, RHCG, CA9, SLC22A7, SLC22A8, SLC7A8, RHBG, UMOD, SLC4A1, ATP6V1B1, AQP2 | |
GO:0005886 ~ plasma membrane | 53 | 4.79E-06 | CLDN8, TLR2, SLC7A8, AQP2, GPC3, CXCR4, TGFBI, SLC4A1, FCGR3A, FCGR3B, DPEP1, KNG1, COL23A1, SLC22A7, SUCLG1, SLC22A8, SLC34A1, TNFSF13B, RHCG, CA9, ATP6V1G3, TREM2, SH3GL2, CHL1, ENPP6, CAV2, CAV1, FXYD4, C3, RHBG, TRIB3, CLCNKB, ITGB2, KCNJ1, ENO2, TMEM30B, FCER1G, HRG, SUCNR1, ENTPD1, TYROBP, SLC12A3, PLG, XPNPEP2, SLC16A3, P2RX7, RGS1, SFRP1, NPHS2, SLC13A3, DIO1, ATP6V0A4, DCXR | |
GO:0005887 ~ integral component of plasma membrane | 25 | 5.00E-05 | CAV2, CAV1, FXYD4, SLC12A3, SLC22A7, ENPP3, SLC22A8, TLR2, RHBG, SLC34A1, SLC7A8, TLR3, CLCNKB, AQP2, SLC16A3, P2RX7, LAPTM5, GPC3, RHCG, NPHS2, FCER1G, SLC13A3, SLC4A1, ENTPD1, TYROBP | |
GO:0016471 ~ vacuolar proton-transporting V-type ATPase complex | 4 | 7.28E-05 | ATP6V1G3, ATP6V1B1, ATP6V0A4, ATP6V0D2 | |
GO:0072562 ~ blood microparticle | 8 | 1.04E-04 | KNG1, C1QB, AFM, C3, HRG, SLC4A1, PLG, ANGPTL4 | |
GO:0005578 ~ proteinaceous extracellular matrix | 10 | 1.24E-04 | CTHRC1, SOST, GPC3, SFRP1, LGALS1, TGFBI, UMOD, FGF1, CHL1, ANGPTL4 | |
GO:0016324 ~ apical plasma membrane | 10 | 2.30E-04 | CAV1, RHCG, SLC12A3, SLC34A1, UMOD, ATP6V1B1, ATP6V0A4, ATP6V0D2, DPEP1, AQP2 | |
GO:0005615 ~ extracellular space | 22 | 4.94E-04 | KNG1, CTHRC1, C3, FGF9, LGALS1, HILPDA, CTSS, PLG, TNFAIP6, AFM, GPC3, SOST, TNFSF13B, SFRP1, SERPINA5, TGFBI, ENO2, CSTA, FGF1, IGFBP3, DPEP1, ANGPTL4 | |
GO:0031225 ~ anchored component of membrane | 6 | 0.001254 | ENPP6, GPC3, UMOD, FCGR3B, DPEP1, XPNPEP2 | |
GO:0016021 ~ integral component of membrane | 53 | 0.002201 | CLDN8, TLR2, SLC7A8, TLR3, AQP2, CXCR4, EVI2A, TMEM52B, SMIM5, SLC4A1, FCGR3A, FCGR3B, COL23A1, SLC22A7, SLC22A8, SLC34A1, DMRT2, HEPACAM2, TNFSF13B, CA9, RHCG, SPAG4, HSD11B2, TREM2, CHL1, NETO2, CAV2, TYRP1, CAV1, TMEM213, ENPP3, RHBG, CLCNKB, UMOD, KCNJ1, SEMA5B, LPCAT1, TMEM30B, FCER1G, HS6ST2, SUCNR1, ENTPD1, MS4A6A, TYROBP, TMEM45A, SLC12A3, NDUFA4L2, HILPDA, GGT6, SFRP1, SLC13A3, DIO1, ATP6V0A4 | |
GO:0043234 ~ protein complex | 10 | 0.002667 | CAV2, CAV1, SOST, PVALB, SERPINA5, NPHS2, DDB2, FABP1, PRKCDBP, BIRC3 | |
GO:0005576 ~ extracellular region | 22 | 0.004463 | KNG1, ENPP6, FGF9, C3, APOC1, UMOD, CTSS, PLG, C1QA, C1QB, AFM, SOST, TNFSF13B, SFRP1, SERPINA5, TGFBI, HRG, FGF1, TREM2, CASP1, IGFBP3, ANGPTL4 | |
GO:0009986 ~ cell surface | 11 | 0.005205 | SFRP1, CXCR4, LGALS1, TLR2, SLC34A1, FCER1G, TLR3, HILPDA, ITGB2, PLG, TYROBP | |
GO:0002080 ~ acrosomal membrane | 3 | 0.007858 | CAV2, CAV1, SERPINA5 | |
GO:0005602 ~ complement component C1 complex | 2 | 0.014107 | C1QA, C1QB | |
GO:0045121 ~ membrane raft | 6 | 0.015662 | CAV2, CAV1, NPHS2, TLR2, SLC34A1, BIRC3 | |
GO:0000139 ~ Golgi membrane | 10 | 0.024687 | CAV2, CAV1, LPCAT1, ST8SIA4, TLR3, HS6ST2, HEPACAM2, MAN1C1, SH3GL2, HPD | |
GO:0005581 ~ collagen trimer | 4 | 0.027574 | C1QA, CTHRC1, C1QB, COL23A1 | |
GO:0005759 ~ mitochondrial matrix | 7 | 0.028942 | PDK1, ALDH6A1, SUCLG1, ALDH4A1, ABAT, PCK2, ACSF2 | |
GO:0005782 ~ peroxisomal matrix | 3 | 0.042028 | ACOX2, FABP1, ACAA1 | |
molecular function | GO:0019864 ~ IgG binding | 4 | 6.11E-05 | FCER1G, UMOD, FCGR3A, FCGR3B |
GO:0008201 ~ heparin binding | 7 | 0.001175 | KNG1, SOST, SFRP1, FGF9, SERPINA5, HRG, FGF1 | |
GO:0005102 ~ receptor binding | 10 | 0.001189 | KNG1, ACOX2, P2RX7, CAV1, TNFSF13B, C3, HRG, HILPDA, PLG, TYROBP | |
GO:0030506 ~ ankyrin binding | 3 | 0.009327 | RHCG, RHBG, SLC4A1 | |
GO:0001530 ~ lipopolysaccharide binding | 3 | 0.011232 | P2RX7, TLR2, TREM2 | |
GO:0043027 ~ cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 3 | 0.012243 | NOL3, BIRC3, DPEP1 | |
GO:0015301 ~ anion:anion antiporter activity | 3 | 0.012243 | SLC22A7, SLC22A8, SLC4A1 | |
GO:0051117 ~ ATPase binding | 4 | 0.017177 | CAV1, FXYD4, ATP6V1G3, ATP6V0A4 | |
GO:0042802 ~ identical protein binding | 12 | 0.022021 | CLDN8, CAV1, NOL3, SFRP1, CRYAA, FBP1, ALDH4A1, TLR3, SH3GL2, DCXR, TYROBP, ANGPTL4 | |
GO:0015078 ~ hydrogen ion transmembrane transporter activity | 3 | 0.022995 | ATP6V1B1, ATP6V0A4, ATP6V0D2 | |
GO:0004869 ~ cysteine-type endopeptidase inhibitor activity | 3 | 0.025762 | KNG1, HRG, CSTA |